Clinical Trial Update: A Study of LN-144 in People With Metastatic Melanoma to the Brain [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LN-144 in people with metastatic melanoma that has spread to the brain. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• LN-144

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING